Skip to main content
Georgia Cancer Info Logo
Donate
Georgia Cancer Info Logo
About Georgia CORENews & HappeningsWays to Give
Advancing ResearchExplore Clinical TrialsCollaboration Opportunities
ScreeningGeorgia Genetics ProgramEducation & NavigationSurvivorship

Check your hereditary breast & ovarian cancer risk with our easy Genetic Screening Tool.

Start risk assessment
Search ResourcesFind Cancer Centers
Donate
Georgia Cancer Info Logo

Contact us

+1-404-523-8735info@georgiacancerinfo.org
999 Peachtree St NE, Suite 400Atlanta, GA 30309

Sign up for news and announcements

  • Home
  • About
  • Contact
  • Facebook
  • LinkedIn
  • Instagram

© 2005 - 2026 Georgia Center for Oncology Research and Education. All Rights Reserved.

PrivacyTerms & Conditions
Michael Baxter
  1. About Us/
  2. Michael Baxter

Michael Baxter

President, Versal Communications

Michael Baxter helps Georgia CORE tell its story in a wide range of communications. For nearly 20 years, he has played a key role in defining and presenting Georgia CORE’s impact and value – both in narrative and through visual communication.

As principal of Versal, a Decatur, Ga.-based creative firm, Michael helps nonprofit organizations, public policy groups and companies communicate more effectively. Similar to Georgia CORE, he has worked with the Georgia Research Alliance, Medical College of Georgia (at Augusta University) and the Georgia Cancer Coalition, the precursor to Georgia CORE.

Michael also served as the first communications director for the CDC Foundation, where he launched a communication program to engage key constituent groups in the vital work of CDC scientists.

Michael Baxter

Keep up to date with Georgia CORE on LinkedIn

Real stories from patients, survivors, and advocates across Georgia.

Follow on LinkedIn
Oct. stakeholder session: Should Georgia have a cancer clinical trials roundtable?

Day 2 of an impressive convening of Georgia CORE partners representing the cancer research, care provider, patient navigation and advocacy communities. Each stakeholder session was an opportunity for these groups to come together and discuss how to carry the recommendations forward of the Georgia House Study Committee on Access to Cancer Care on day 1; and the state of cancer clinical trials in Georgia on day 2. Be on the look out for the forthcoming report of these impactful two days!